

400-9696-311 转1

400-9696-311 转2

400-9696-311 转3

400-9696-311 转4
ChiCTR-TRC-14004478
正在进行
/
/
/
2014-04-10
/
/
Elective surgery with potential massive blood loss requiring blood transfusion
圍手術期輸血指征評分(Peri-Operative Transfusion Trigger Score, POTTS)安全性與有效性的多中心,隨機,對照臨床研究
圍手術期輸血指征評分(Peri-Operative Transfusion Trigger Score, POTTS)安全性與有效性的多中心,隨機,對照臨床研究
圍手術期輸血指征評分(Peri-Operative Transfusion Trigger Score, POTTS)安全性與有效性
随机平行对照
其它
Randomized
pen label
Prince of Wales Hospital, Shatin, Hong Kong
/
20
/
2014-02-20
1990-01-01
/
1. Age older than 14 weeks old; 2. Live in an area of altitude shorter than 2500 m most of the time; 3. Estimated intraoperative blood loss more than 1000ml, or more than 20% of total blood volume.;
登录查看1. Emergency surgery; 2. Patients with physical status of ASA class V or above; 3. Patients with known severe haematological disorders; 4. Patients with known haemaglobinopathy; 5. Acute hypervolemic haemodilution is planned; 6. Patients with known metastatic cancer or more than one neoplasm concurrently; 7. Other conditions that may preclude the patients from the study, such as language barrier, psychiatric disorders, unable to attend research center for follow up; 8. Patients who enrolled to another research study or are taking experimental medication in last 3 months prior to this study; 9. Not suitable for the study, after assessment by the investigators.;
登录查看Prince of Wales Hospital, Shatin, Hong Kong
/
谱新生物Hillgene2025-10-21
药研网2025-10-21
求实药社2025-10-21
求实药社2025-10-21
求实药社2025-10-21
佰傲谷BioValley2025-10-21
醴泽资本 LYZZCapital2025-10-21
信立泰药业2025-10-21
康威生物2025-10-21
数字医疗2025-10-21